Call for Applications: The Amgen Award for Science Teaching Excellence



    32 Outstanding Teachers Will Be Recognized in Communities Where Amgen
Operates

    THOUSAND OAKS, CALIF., November 1 /CNW/ - Amgen (NASDAQ:  AMGN) today
announced that it now invites applications for its 17th annual Amgen Award for
Science Teaching Excellence. This award is designed to recognize and honor
extraordinary science teachers at the K-12 level, who significantly impact
their students through exemplary science teaching and who achieve demonstrated
results in student learning in communities where Amgen operates.

    With a longstanding commitment to science education, Amgen established
the teacher awards program to promote and encourage science excellence in
public and private schools. Since the program's inception in 1992, Amgen has
awarded more than $1.7 million to educators who have made exceptional
science-teaching contributions and who have significantly impacted the lives
of their students. Amgen is expanding its program this year, and will honor a
total of 32 teachers in California, Colorado, Kentucky, Massachusetts, Puerto
Rico, Rhode Island, Washington and Canada (British Columbia and Ontario).

    "An inspirational teacher can truly make a difference for students," said
Phyllis Piano, vice president Corporate Communications and Philanthropy.
"Amgen is proud to honor educators who inspire their students to learn more
about the wonders of science."

    The 32 selected winners within the United States, Puerto Rico and Canada
will receive the following benefits:

    --  An unrestricted cash award of $5,000USD or $5,000CAD;

    --  A restricted $5,000USD or $5,000CAD cash grant to the recipient's
school for the expansion or enhancement of a school science program, science
resources, or the professional development of the school's science teachers

    Applicants are also required to submit an innovative lesson plan that
they have successfully incorporated into their classroom and can be shared
with other teachers. A panel of independent judges will select the winners
based on the following criteria: creativity of teaching methods; innovative
lesson plan; effectiveness in the classroom and the plan for the use of grant
money to improve science education resources in their schools.

    A select number of the lesson plans submitted by 2008 AASTE Award winners
will be posted to Amgen's Web site, with the intent that other teachers will
benefit from these innovative materials. Select lesson plans from 2007 AASTE
Award winners are available for download at no cost; educators are encouraged
to review and implement any of these plans into their own curriculum.

    Those interested in applying should visit
http://www.amgen.com/citizenship/aaste.html for more information. Applications
must be postmarked by Jan. 31, 2008 to be valid. Winners will be notified in
May 2008.

    About Amgen

    Amgen discovers, develops and delivers innovative human therapeutics. A
biotechnology pioneer since 1980, Amgen was one of the first companies to
realize the new science's promise by bringing safe and effective medicines
from lab, to manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the world in the
fight against cancer, kidney disease, rheumatoid arthritis, and other serious
illnesses. With a deep and broad pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve people's lives.
To learn more about our pioneering science and our vital medicines, visit
www.amgen.com.




For further information:

For further information: Amgen, Thousand Oaks Sarah Rockwell,
805-447-9953 (media)

Organization Profile

AMGEN INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890